China Pharma Holdings (CPHI) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $300000.0.
- China Pharma Holdings' Cash & Current Investments fell 5825.74% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $300000.0, marking a year-over-year decrease of 5825.74%. This contributed to the annual value of $626879.0 for FY2024, which is 5597.26% down from last year.
- China Pharma Holdings' Cash & Current Investments amounted to $300000.0 in Q3 2025, which was down 5825.74% from $625032.0 recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Cash & Current Investments ranged from a high of $4.9 million in Q4 2021 and a low of $300000.0 during Q3 2025
- Its 5-year average for Cash & Current Investments is $1.4 million, with a median of $901910.0 in 2023.
- Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 59496.75% in 2022, then plummeted by 6858.66% in 2023.
- Over the past 5 years, China Pharma Holdings' Cash & Current Investments (Quarter) stood at $4.9 million in 2021, then crashed by 58.22% to $2.0 million in 2022, then dropped by 29.86% to $1.4 million in 2023, then crashed by 55.97% to $626879.0 in 2024, then crashed by 52.14% to $300000.0 in 2025.
- Its Cash & Current Investments was $300000.0 in Q3 2025, compared to $625032.0 in Q2 2025 and $412688.0 in Q1 2025.